List of bibliographic references indexed by Syndrome respiratoire aigu sévère (traitement médicamenteux)
Number of relevant bibliographic references: 196.
[20-40] [
0 - 20][
0 - 50][
40-60]
| Ident. | Authors (with country if any) | Title |
|---|
| 001838 (2013) |
Jasper Fuk-Woo Chan [République populaire de Chine] ; Susanna Kar-Pui Lau [République populaire de Chine] ; Patrick Chiu-Yat Woo [République populaire de Chine] | The emerging novel Middle East respiratory syndrome coronavirus: The “knowns” and “unknowns” |
| 001840 (2013) |
Wooseong Lee [Corée du Sud] ; Seung-Hoon Lee ; Dae-Gyun Ahn ; Hee Cho ; Moon-Hee Sung ; Seung Hyun Han ; Jong-Won Oh | The antiviral activity of poly-γ-glutamic acid, a polypeptide secreted by Bacillus sp., through induction of CD14-dependent type I interferon responses. |
| 001954 (2013) |
Mark Turlington [États-Unis] ; Aspen Chun ; Sakshi Tomar ; Aimee Eggler ; Valerie Grum-Tokars ; Jon Jacobs ; J Scott Daniels ; Eric Dawson ; Adrian Saldanha ; Peter Chase ; Yahira M. Baez-Santos ; Craig W. Lindsley ; Peter Hodder ; Andrew D. Mesecar ; Shaun R. Stauffer | Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding. |
| 001960 (2013) |
Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Jung Min Kwon ; Hyung-Jun Kwon ; Hyung Jae Jeong ; Young Min Kim ; Doman Kim ; Woo Song Lee ; Young Bae Ryu | Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. |
| 001991 (2013) |
Vathan Kumar ; Young-Sik Jung ; Po-Huang Liang | Anti-SARS coronavirus agents: a patent review (2008 - present). |
| 001C08 (2013) |
Rolf Hilgenfeld [Allemagne] ; Malik Peiris [Hong Kong] | From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses |
| 001C44 (2012) |
Ji-Young Park [Corée du Sud] ; Jang Hoon Kim ; Young Min Kim ; Hyung Jae Jeong ; Dae Wook Kim ; Ki Hun Park ; Hyung-Jun Kwon ; Su-Jin Park ; Woo Song Lee ; Young Bae Ryu | Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases. |
| 001C51 (2012) |
Menno D. De Jong ; Frederick G. Hayden | Spotlight on respiratory viruses 2012: introduction. |
| 001C54 (2012) |
Adeyemi O. Adedeji [États-Unis] ; Kamalendra Singh ; Nicholas E. Calcaterra ; Marta L. Dediego ; Luis Enjuanes ; Susan Weiss ; Stefan G. Sarafianos | Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase. |
| 001C57 (2012) |
Garyphallia Poulakou [Espagne] ; Marcos Pérez ; Jordi Rello | Severe acute respiratory infections in the postpandemic era of H1N1. |
| 001C60 (2012) |
Susan Matthews | Select-agent status could slow development of anti-SARS therapies. |
| 001C86 (2012) |
Ning Yang [République populaire de Chine] ; Ping Ma ; Jianshe Lang ; Yanli Zhang ; Jiejie Deng ; Xiangwu Ju ; Gongyi Zhang ; Chengyu Jiang | Phosphatidylinositol 4-kinase IIIβ is required for severe acute respiratory syndrome coronavirus spike-mediated cell entry. |
| 001D36 (2012) |
Young-Sam Keum [Corée du Sud] ; Yong-Joo Jeong | Development of chemical inhibitors of the SARS coronavirus: viral helicase as a potential target. |
| 001D62 (2012) |
Andreas J. Kesel [Allemagne] ; Hans-Christoph Weiss ; Andreas Schönleber ; Craig W. Day ; Dale L. Barnard ; Mervi A. Detorio ; Raymond F. Schinazi | Antiviral agents derived from novel 1-adamantyl singlet nitrenes. |
| 001D70 (2012) |
Rachel L. Graham ; Michelle M. Becker ; Lance D. Eckerle ; Meagan Bolles ; Mark R. Denison ; Ralph S. Baric | A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease |
| 001F62 (2012) |
Miyuki Kawase [Japon] ; Kazuya Shirato [Japon] ; Lia Van Der Hoek [Pays-Bas] ; Fumihiro Taguchi [Japon] ; Shutoku Matsuyama [Japon] | Simultaneous Treatment of Human Bronchial Epithelial Cells with Serine and Cysteine Protease Inhibitors Prevents Severe Acute Respiratory Syndrome Coronavirus Entry |
| 002004 (2011) |
V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev | [Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome]. |
| 002005 (2011) |
V N Shchukina ; S Ia Loginova ; S V Borisevich ; V P Bondarev | [Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV]. |
| 002010 (2011) |
Qiaoli Li [République populaire de Chine] ; Zhenhuan Zhao ; Dihan Zhou ; Yaoqing Chen ; Wei Hong ; Luyang Cao ; Jingyi Yang ; Yan Zhang ; Wei Shi ; Zhijian Cao ; Yingliang Wu ; Huimin Yan ; Wenxin Li | Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. |
| 002028 (2011) |
Susanne Pfefferle [Allemagne] ; Julia Schöpf [Allemagne] ; Manfred Kögl [Allemagne] ; Caroline C. Friedel [Allemagne] ; Marcel A. Müller [Allemagne] ; Javier Carbajo-Lozoya [Allemagne] ; Thorsten Stellberger [Allemagne] ; Ekatarina Von Dall Rmi [Allemagne] ; Petra Herzog [Allemagne] ; Stefan Kallies [Allemagne] ; Daniela Niemeyer [Allemagne] ; Vanessa Ditt [Allemagne] ; Thomas Kuri [Allemagne] ; Roland Züst [Suisse] ; Ksenia Pumpor [Allemagne] ; Rolf Hilgenfeld [Allemagne] ; Frank Schwarz [Allemagne] ; Ralf Zimmer [Allemagne] ; Imke Steffen [Allemagne] ; Friedemann Weber [Allemagne] ; Volker Thiel [Suisse] ; Georg Herrler [Allemagne] ; Heinz-Jürgen Thiel [Allemagne] ; Christel Schwegmann-We Els [Allemagne] ; Stefan Pöhlmann [Allemagne] ; Jürgen Haas [Allemagne, Royaume-Uni] ; Christian Drosten [Allemagne] ; Albrecht Von Brunn [Allemagne] | The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors |
| 002094 (2011) |
Yohichi Kumaki [États-Unis] ; Miles K. Wandersee ; Aaron J. Smith ; Yanchen Zhou ; Graham Simmons ; Nathan M. Nelson ; Kevin W. Bailey ; Zachary G. Vest ; Joseph K-K Li ; Paul Kay-Sheung Chan ; Donald F. Smee ; Dale L. Barnard | Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Syndrome respiratoire aigu sévère (traitement médicamenteux)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i \
-Sk "Syndrome respiratoire aigu sévère (traitement médicamenteux)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdFr.i
|clé= Syndrome respiratoire aigu sévère (traitement médicamenteux)
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021 |  |
